Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution Nokia Q1 2026 Earnings EPS Beats Estimates by 2285 as Cost Discipline Drives Profitability ENDRA Life Sciences Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Continues Development STZ Q1 2026 Earnings EPS Surprises to the Upside Stock Slips XXII Q1 2026 Earnings Significant EPS Miss Highlights Continued Challenges